These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 22353234)

  • 1. Use of cilostazol for secondary stroke prevention: an old dog with new tricks?
    Ansara AJ; Shiltz DL; Slavens JB
    Ann Pharmacother; 2012 Mar; 46(3):394-402. PubMed ID: 22353234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis.
    Niu PP; Guo ZN; Jin H; Xing YQ; Yang Y
    BMJ Open; 2016 Mar; 6(3):e009013. PubMed ID: 26988347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination antiplatelet agents for secondary prevention of ischemic stroke.
    Vande Griend JP; Saseen JJ
    Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin dosing for the prevention and treatment of ischemic stroke: an indication-specific review of the literature.
    Ansara AJ; Nisly SA; Arif SA; Koehler JM; Nordmeyer ST
    Ann Pharmacother; 2010 May; 44(5):851-62. PubMed ID: 20388864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antiplatelet therapy: update in secondary stroke prevention].
    Uchiyama S
    Brain Nerve; 2013 Jul; 65(7):771-82. PubMed ID: 23832980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protocol for Cilostazol Stroke Prevention Study for Antiplatelet Combination (CSPS.com): a randomized, open-label, parallel-group trial.
    Toyoda K; Uchiyama S; Hoshino H; Kimura K; Origasa H; Naritomi H; Minematsu K; Yamaguchi T;
    Int J Stroke; 2015 Feb; 10(2):253-8. PubMed ID: 25487817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet therapy in cerebrovascular disorders.
    Weber R; Brenck J; Diener HC
    Handb Exp Pharmacol; 2012; (210):519-46. PubMed ID: 22918745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cilostazol may prevent cardioembolic stroke in patients undergoing antiplatelet therapy.
    Horie N; Kaminogo M; Izumo T; Hayashi K; Tsujino A; Nagata I
    Neurol Res; 2015 Jul; 37(7):619-23. PubMed ID: 25798683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].
    Kirshner HS
    Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplatelets in secondary stroke prevention: should clopidogrel be the first choice?
    Aw D; Sharma JC
    Postgrad Med J; 2012 Jan; 88(1035):34-7. PubMed ID: 22121248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use.
    Reaume KT; Regal RE; Dorsch MP
    Ann Pharmacother; 2008 Apr; 42(4):550-7. PubMed ID: 18319394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cilostazol in Acute Ischemic Stroke Treatment (CAIST Trial): a randomized double-blind non-inferiority trial.
    Lee YS; Bae HJ; Kang DW; Lee SH; Yu K; Park JM; Cho YJ; Hong KS; Kim DE; Kwon SU; Lee KB; Rha JH; Koo J; Han MG; Lee SJ; Lee JH; Jung SW; Lee BC; Kim JS
    Cerebrovasc Dis; 2011; 32(1):65-71. PubMed ID: 21613787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefit of cilostazol in patients with high risk of bleeding: subanalysis of cilostazol stroke prevention study 2.
    Uchiyama S; Shinohara Y; Katayama Y; Yamaguchi T; Handa S; Matsuoka K; Ohashi Y; Tanahashi N; Yamamoto H; Genka C; Kitagawa Y; Kusuoka H; Nishimaru K; Tsushima M; Koretsune Y; Sawada T; Hamada C
    Cerebrovasc Dis; 2014; 37(4):296-303. PubMed ID: 24820203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale and design of the PreventIon of CArdiovascular events in iSchemic Stroke patients with high risk of cerebral hemOrrhage (PICASSO) study: A randomized controlled trial.
    Hong KS; Kim BJ; Lee JY; Kwon SU;
    Int J Stroke; 2015 Oct; 10(7):1153-8. PubMed ID: 26044566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cilostazol in secondary prevention of stroke: impact of the Cilostazol Stroke Prevention Study.
    Matsumoto M
    Atheroscler Suppl; 2005 Dec; 6(4):33-40. PubMed ID: 16275125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the inflammatory response in secondary stroke prevention: a role for combining aspirin and extended-release dipyridamole.
    Weyrich AS; Skalabrin EJ; Kraiss LW
    Am J Ther; 2009; 16(2):164-70. PubMed ID: 19300042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aggrenox: a fixed-dose combination of aspirin and dipyridamole.
    Lenz TL; Hilleman DE
    Ann Pharmacother; 2000 Nov; 34(11):1283-90. PubMed ID: 11098344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary stroke prevention with antiplatelet drugs: have we reached the ceiling?
    Diener HC
    Int J Stroke; 2006 Feb; 1(1):4-8. PubMed ID: 18706062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines.
    Hankey GJ
    Curr Med Res Opin; 2007 Jun; 23(6):1453-62. PubMed ID: 17559741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy and safety of multiple antiplatelet therapies for secondary prevention of ischemic stroke or transient ischemic attack: A network meta-analysis.
    Xiang RW; Han RB; Yang JY; Zhao MY; Zhao QC; Chen HS; Zhao FQ; Sun ZY; Zhao T; Song TY
    J Neurol Sci; 2019 Apr; 399():199-206. PubMed ID: 30849580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.